Revised MRPs post GST rate reduction, effective 22nd September – Making healthcare more affordable. Learn More
Delivering healthcare solutions globally with a patient-centric approach
Mankind’s philosophy of innovative yet affordable healthcare is a universal need. So, it is no wonder that Mankind has been able to win hearts and markets in 35 countries across the globe through our core values of serviceability, transparency, and patient-centric values.
Products approved across 25+ countries
140+
Products approved across 40+ countries
Regulatory approvals Including USFDA, EU GMP, ANVISA, PIC/S, UAE
20+
Regulatory approvals Including USFDA, EU GMP, ANVISA, PIC/S, UAE
Niche Products in pipeline across Cardiovascular, Diabetology, Urology and Hormones
30+
Niche Products in pipeline across Cardiovascular, Diabetology, Urology and Hormones
Strong Presence
Strong Presence
In Women’s Health, Complex Injectables, Ophthalmics, Dermatology, CVS & Metabolic
emerging market presence
Our Presence in
Overseas Market
Since its inception, Mankind aspires to be customer-centric and a leader in the Global markets. Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare to all sections of the society. Today, Mankind operates in 34 countries across the Globe.
Afghanistan
Algeria
Australia
Belgium
Brazil
Cambodia
Chile
China
Costa Rica
Denmark
Finland
France
Germany
Guatemala
Hong Kong
Indonesia
Iraq
Ireland
Jordan
Kenya
Lebanon
Malaysia
Mexico
Mongolia
Morocco
Myanmar
Nepal
Netherlands
New Zealand
Norway
Oman
Pakistan
Panama
Peru
Philippines
Poland
Russia
Saudi Arabia
Singapore
South Africa
Sri Lanka
Sweden
Tanzania
Thailand
UAE
Uganda
United Kingdom
Formulating business success
Formulating business success
Serviceability
Closer to the customer. Developing products as per market-specific needs.
Patient Centricity
Clear therapy-focused approach, targeting the Chronic Segments
Transparency
Mankind Corporate philosophy of better reach, Transparency & affordability
The emerging presence in Emerging Markets
Mankind’s innovative DNA comes to the fore in regulated emerging markets. Our pioneering R&D division has the capacity to develop niche molecules specific to emerging global markets. Over 26 niche products are currently in the pipeline at various stages of development, and more products are being regularly added.
The emerging presence in Emerging Markets